Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
179,900
-1,000 (-0.55%)
Feb 21, 2025, 3:30 PM KST
163.78%
Market Cap 4.18T
Revenue (ttm) 208.22B
Net Income (ttm) 5.11B
Shares Out 23.26M
EPS (ttm) 221.48
PE Ratio 818.76
Forward PE n/a
Dividend 200.00 (0.11%)
Ex-Dividend Date Dec 27, 2024
Volume 209,361
Average Volume 600,698
Open 179,700
Previous Close 180,900
Day's Range 177,300 - 183,400
52-Week Range 68,400 - 230,000
Beta 1.40
RSI 53.98
Earnings Date Feb 7, 2025

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.